Soft tissue sarcoma nomograms and their incorporation into practice

Research output: Contribution to journalReview article

Abstract

The accurate prediction of prognosis in patients with soft tissue sarcoma (STS) is a challenging issue. Extreme variability in the clinical and pathological characteristics of this family of tumors hinders the simple stratification of patients into meaningful prognostic cohorts. Precision medicine tools for the prediction of prognosis, such as nomograms, enable personalized computation of outcome based on clinical and pathological characteristics of both patient and tumor. The eighth edition of the American Joint Committee on Cancer staging manual moved from a “population-based” to a “personalized” approach endorsing high-quality nomograms to improve clinician prediction ability in definite patient subgroups. The first nomogram for STS was published in 2002, and this was followed by several prognostic predictors offered to clinicians. Focusing on a specific STS subgroup or site, nomograms can take into consideration highly specific factors relevant only in that particular scenario, thereby maximizing prognostic ability. The objective of this review was to critically evaluate available nomograms for patients with STS to provide clinicians and researchers with a choice of the most optimal tool for each specific patient. Cancer 2017;123:2802–20.

Original languageEnglish
Pages (from-to)2802-2820
Number of pages19
JournalCancer
Volume123
Issue number15
DOIs
Publication statusPublished - Aug 1 2017

Fingerprint

Nomograms
Sarcoma
Aptitude
Neoplasms
Precision Medicine
Neoplasm Staging
Research Personnel
Population

Keywords

  • American Joint Committee on Cancer (AJCC)
  • liposarcoma
  • nomogram
  • prediction tool
  • prognosis
  • retroperitoneal sarcoma
  • sarcoma
  • soft tissue sarcoma
  • staging
  • synovial sarcoma

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Soft tissue sarcoma nomograms and their incorporation into practice. / Callegaro, Dario; Miceli, Rosalba; Mariani, Luigi; Raut, Chandrajit P.; Gronchi, Alessandro.

In: Cancer, Vol. 123, No. 15, 01.08.2017, p. 2802-2820.

Research output: Contribution to journalReview article

@article{41d7875dcbe14bb6bfce90aa4df95879,
title = "Soft tissue sarcoma nomograms and their incorporation into practice",
abstract = "The accurate prediction of prognosis in patients with soft tissue sarcoma (STS) is a challenging issue. Extreme variability in the clinical and pathological characteristics of this family of tumors hinders the simple stratification of patients into meaningful prognostic cohorts. Precision medicine tools for the prediction of prognosis, such as nomograms, enable personalized computation of outcome based on clinical and pathological characteristics of both patient and tumor. The eighth edition of the American Joint Committee on Cancer staging manual moved from a “population-based” to a “personalized” approach endorsing high-quality nomograms to improve clinician prediction ability in definite patient subgroups. The first nomogram for STS was published in 2002, and this was followed by several prognostic predictors offered to clinicians. Focusing on a specific STS subgroup or site, nomograms can take into consideration highly specific factors relevant only in that particular scenario, thereby maximizing prognostic ability. The objective of this review was to critically evaluate available nomograms for patients with STS to provide clinicians and researchers with a choice of the most optimal tool for each specific patient. Cancer 2017;123:2802–20.",
keywords = "American Joint Committee on Cancer (AJCC), liposarcoma, nomogram, prediction tool, prognosis, retroperitoneal sarcoma, sarcoma, soft tissue sarcoma, staging, synovial sarcoma",
author = "Dario Callegaro and Rosalba Miceli and Luigi Mariani and Raut, {Chandrajit P.} and Alessandro Gronchi",
year = "2017",
month = "8",
day = "1",
doi = "10.1002/cncr.30721",
language = "English",
volume = "123",
pages = "2802--2820",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "15",

}

TY - JOUR

T1 - Soft tissue sarcoma nomograms and their incorporation into practice

AU - Callegaro, Dario

AU - Miceli, Rosalba

AU - Mariani, Luigi

AU - Raut, Chandrajit P.

AU - Gronchi, Alessandro

PY - 2017/8/1

Y1 - 2017/8/1

N2 - The accurate prediction of prognosis in patients with soft tissue sarcoma (STS) is a challenging issue. Extreme variability in the clinical and pathological characteristics of this family of tumors hinders the simple stratification of patients into meaningful prognostic cohorts. Precision medicine tools for the prediction of prognosis, such as nomograms, enable personalized computation of outcome based on clinical and pathological characteristics of both patient and tumor. The eighth edition of the American Joint Committee on Cancer staging manual moved from a “population-based” to a “personalized” approach endorsing high-quality nomograms to improve clinician prediction ability in definite patient subgroups. The first nomogram for STS was published in 2002, and this was followed by several prognostic predictors offered to clinicians. Focusing on a specific STS subgroup or site, nomograms can take into consideration highly specific factors relevant only in that particular scenario, thereby maximizing prognostic ability. The objective of this review was to critically evaluate available nomograms for patients with STS to provide clinicians and researchers with a choice of the most optimal tool for each specific patient. Cancer 2017;123:2802–20.

AB - The accurate prediction of prognosis in patients with soft tissue sarcoma (STS) is a challenging issue. Extreme variability in the clinical and pathological characteristics of this family of tumors hinders the simple stratification of patients into meaningful prognostic cohorts. Precision medicine tools for the prediction of prognosis, such as nomograms, enable personalized computation of outcome based on clinical and pathological characteristics of both patient and tumor. The eighth edition of the American Joint Committee on Cancer staging manual moved from a “population-based” to a “personalized” approach endorsing high-quality nomograms to improve clinician prediction ability in definite patient subgroups. The first nomogram for STS was published in 2002, and this was followed by several prognostic predictors offered to clinicians. Focusing on a specific STS subgroup or site, nomograms can take into consideration highly specific factors relevant only in that particular scenario, thereby maximizing prognostic ability. The objective of this review was to critically evaluate available nomograms for patients with STS to provide clinicians and researchers with a choice of the most optimal tool for each specific patient. Cancer 2017;123:2802–20.

KW - American Joint Committee on Cancer (AJCC)

KW - liposarcoma

KW - nomogram

KW - prediction tool

KW - prognosis

KW - retroperitoneal sarcoma

KW - sarcoma

KW - soft tissue sarcoma

KW - staging

KW - synovial sarcoma

UR - http://www.scopus.com/inward/record.url?scp=85019075046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019075046&partnerID=8YFLogxK

U2 - 10.1002/cncr.30721

DO - 10.1002/cncr.30721

M3 - Review article

C2 - 28493287

AN - SCOPUS:85019075046

VL - 123

SP - 2802

EP - 2820

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 15

ER -